Delivery Order SPE2DB22D2006-SPE2DB24FW1MG

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a $2,264.24 delivery order for the supply of 4,566,776,597 tablets of the medication Klonopin 0.5 mg. The contract has an ultimate completion date of December 23, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of KLONOPIN 0.5 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,835.86 and a period of performance through June 6, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FL1WU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,572.32 fixed-price delivery order is for the supply of 4565056084 Klonopin 0.5 mg tablets. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, a ceiling value of $1,043.04, and an ultimate completion date of April 16, 2025. The contract is for the supply of 4,567,920 units of the prescription medication Klonopin (0.5 mg tablet, 100s) to support federal medical procurement...
This federal contract award, SPE2DB22D3016|SPE2DB25FALC7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.82 Firm Fixed Price Delivery Order covers the supply of 4567027865 KLONOPIN 0.5 MG TABLET 100S, with a performance period through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,030.36 firm fixed-price delivery order is for the supply of KLONOPIN 0.5 MG TABLET 100S, a medication used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,840.10, is for the delivery of CLONIDINE HCL ER 0.1 MG TABLET 60S. This is a firm fixed-price delivery order contract with an ultimate completion date of November 24, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award is for the delivery of 4,563,801,118 units of clobazam 10 mg tablets to the Defense Logistics Agency (DLA). The $5,001.49 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,071.00, is a Firm Fixed Price Delivery Order for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1MG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,054.87 that was issued by the Defense Logistics Agency (DLA) to provide Klonopin 1 mg tablets. The contract has a completion date of July 1, 2024 and utilizes a Firm Fixed Price pricing type.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order award is part of that larger IDC. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 5/17/25, 10:11 AM